News
-
-
COMMUNIQUÉ DE PRESSE
Mainz Biomed Initiates U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population
Mainz Biomed initiates U.S. clinical study to evaluate next-generation CRC test on advanced adenomas over large patient population. Study targets topline results by Q4 2025, focusing on biomarkers and AI algorithm -
-
COMMUNIQUÉ DE PRESSE
NOA Lithium Announces Director Changes
NOA Lithium Brines Inc.(TSXV:NOAL) announces resignation of directors and appointment of new board members to pursue other opportunities. The TSX Venture Exchange to review and approve. Company aims to reach major milestones at Rio Grande project -
-
-
COMMUNIQUÉ DE PRESSE
The Now Corporation (OTC: NWPN) Sees Opportunities for Community Solar Projects in California
The Now Corporation (OTCPINK:NWPN) expands into California's community solar market with a focus on battery storage technology under Assembly Bill 2316, aiming for grid stability and reliability -
COMMUNIQUÉ DE PRESSE
Original-Research: Lisata Therapeutics Inc (von First Berlin Equity Research GmbH): BUY
First Berlin Equity Research initiates coverage on Lisata Therapeutics Inc, a US pharmaceutical company focusing on innovative therapies for solid tumors. Analyst recommends BUY with USD15.00 target price -
-
